Erratum: Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation (Proceedings of the National Academy of Sciences of the United States of America (2013) 110: (E4345-E4354) DOI: 10.1073/pnas.1303641110);Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 46, 2013, Pages 20843-

  Paciello, Ida ^a   Silipo, Alba ^b   Lembo Fazio, Luigi ^a   Curcurù, Laura ^a   Zumsteg, Anna ^c   Noël, Gaëlle ^a   Ciancarella, Valeria ^a   Sturiale, Luisa ^d   Molinaro, Antonio ^b   Bernardini, Maria Lina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d Istituto di Chimica e Tecnologia dei Polimeri   (Italy)

Author keywords

Enteric pathogen; Immune evasion; Innate immunity; PAMPs PRRs

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INFLAMMASOME; LIPID A; TOLL LIKE RECEPTOR 4;

ACYLATION; ANTIGEN RECOGNITION; ARTICLE; IMMUNE SYSTEM; INNATE IMMUNITY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RECTUM MUCOSA; RESPIRATORY BURST; SHIGELLA;

BACTERIA (MICROORGANISMS); SHIGELLA; SHIGELLA FLEXNERI;

EID: 84887431806     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320851110     Document Type: Erratum

References (70)

1. Hoshino K, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162(7):3749-3752. (Pubitemid 29314747)
2. Shimazu R, et al. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189(11):1777-1782. (Pubitemid 29272694)
3. Takeda K, Akira S (2004) Microbial recognition by Toll-like receptors. J Dermatol Sci 34(2):73-82. (Pubitemid 38368945)
4. Schletter J, Heine H, Ulmer AJ, Rietschel ET (1995) Molecular mechanisms of endotoxin activity. Arch Microbiol 164(6):383-389. (Pubitemid 26018509)
5. Raetz CR, Reynolds CM, Trent MS, Bishop RE (2007) Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 76:295-329.
6. Wang X, Quinn PJ (2010) Endotoxins: Lipopolysaccharides of gram-negative bacteria. Subcell Biochem 53:3-25.
7. DeMarco ML, Woods RJ (2011) From agonist to antagonist: Structure and dynamics of innate immune glycoprotein MD-2 upon recognition of variably acylated bacterial endotoxins. Mol Immunol 49(1-2):124-133.
8. Kawahara K, Tsukano H, Watanabe H, Lindner B, Matsuura M (2002) Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect Immun 70(8):4092-4098. (Pubitemid 34790917)
9. Guo L, et al. (1997) Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276(5310):250-253. (Pubitemid 27172682)
10. Pier GB (2007) Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol 297(5):277-295.
11. Cigana C, et al. (2009) Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PloS One 4(12):e8439.
12. DuPont HL, Levine MM, Hornick RB, Formal SB (1989) Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 159(6):1126-1128. (Pubitemid 19138818)
13. Ogawa M, Handa Y, Ashida H, Suzuki M, Sasakawa C (2008) The versatility of Shigella effectors. Nat Rev Microbiol 6(1):11-16. (Pubitemid 350286216)
14. Clerc PJ, Ryter A, Mounier J, Sansonetti PJ (1986) Plasmid-mediated intracellular multiplication of Shigella flexneri. Ann Inst Pasteur Microbiol 137A(3):315-320. (Pubitemid 16058362)
15. Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J (1986) Multiplication of Shigella flexneri within HeLa cells: Lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect Immun 51(2):461-469. (Pubitemid 16212121)
16. Philpott DJ, Yamaoka S, Israël A, Sansonetti PJ (2000) Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol 165(2):903-914. (Pubitemid 30484758)
17. Girardin SE, et al. (2001) CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2(8):736-742. (Pubitemid 32798718)
18. Sansonetti PJ, Tran Van Nhieu G, Egile C (1999) Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri. Clin Infect Dis 28(3):466-475. (Pubitemid 29242519)
19. Suzuki T, et al. (2005) A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages. J Biol Chem 280(14):14042-14050. (Pubitemid 40517305)
20. Martinon F, Burns K, Tschopp J (2002) The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10(2):417-426. (Pubitemid 35007355)
21. Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: Host cell death and inflammation. Nat Rev Microbiol 7(2):99-109.
22. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140(6):821-832.
23. Suzuki T, et al. (2007) Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PloS Pathog 3(8):e111.
24. Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M (1995) Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest 96(2):884-892.
25. Arondel J, Singer M, Matsukawa A, Zychlinsky A, Sansonetti PJ (1999) Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis. Infect Immun 67(11):6056-6066. (Pubitemid 29508137)
26. Sansonetti PJ, et al. (2000) Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 12(5):581-590.
27. Lembo-Fazio L, et al. (2011) Gadd45α activity is the principal effector of Shigella mitochondria-dependent epithelial cell death in vitro and ex vivo. Cell Death Dis 2:e122.
28. D'Hauteville H, et al. (2002) Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium. J Immunol 168(10):5240-5251. (Pubitemid 34495992)
29. Ranallo RT, et al. (2010) Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants. Infect Immun 78(1):400-412.
30. Cersini A, Salvia AM, Bernardini ML (1998) Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infect Immun 66(2):549-557. (Pubitemid 28074194)
31. De Castro C, Parrilli M, Holst O, Molinaro A (2010) Microbe-associated molecular patterns in innate immunity: Extraction and chemical analysis of gram-negative bacterial lipopolysaccharides. Methods Enzymol 480:89-115.
32. Molinaro A, et al. (2008) Full structural characterization of Shigella flexneri M90T serotype 5 wild-type R-LPS and its delta galU mutant: Glycine residue location in the inner core of the lipopolysaccharide. Glycobiology 18(3):260-269. (Pubitemid 351359693)
33. Sturiale L, et al. (2011) Reflectron MALDI TOF and MALDI TOF/TOF mass spectrometry reveal novel structural details of native lipooligosaccharides. J Mass Spectrom 46(11): 1135-1142.
34. Nigro G, et al. (2008) Muramylpeptide shedding modulates cell sensing of Shigella flexneri. Cell Microbiol 10(3):682-695. (Pubitemid 351194095)
35. Erridge C, Kennedy S, Spickett CM, Webb DJ (2008) Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J Biol Chem 283(36):24748-24759.
36. Park BS, et al. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458(7242):1191-1195.
37. Kim HM, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130(5, issue 5):906-917. (Pubitemid 47332573)
38. Ohto U, Fukase K, Miyake K, Satow Y (2007) Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316(5831):1632-1634. (Pubitemid 46982039)
39. Kagan JC, Medzhitov R (2006) Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125(5):943-955. (Pubitemid 43795199)
40. Zanoni I, et al. (2011) CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147(4):868-880.
41. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7):499-511. (Pubitemid 38931765)
42. Carrigan SO, et al. (2010) IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice. J Immunol 185(6):3602-3609.
43. Broz P, Monack DM (2011) Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev 243(1):174-190.
44. Willingham SB, et al. (2007) Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe 2(3):147-159. (Pubitemid 47355205)
45. Koterski JF, Nahvi M, Venkatesan MM, Haimovich B (2005) Virulent Shigella flexneri causes damage to mitochondria and triggers necrosis in infected human monocyte-derived macrophages. Infect Immun 73(1):504-513. (Pubitemid 40041145)
46. Nonaka T, Kuwae A, Sasakawa C, Imajoh-Ohmi S (1999) Shigella flexneri YSH6000 induces two types of cell death, apoptosis and oncosis, in the differentiated human monoblastic cell line U937. FEMS Microbiol Lett 174(1):89-95. (Pubitemid 29179437)
47. Edgeworth JD, Spencer J, Phalipon A, Griffin GE, Sansonetti PJ (2002) Cytotoxicity and interleukin-1beta processing following Shigella flexneri infection of human monocyte-derived dendritic cells. Eur J Immunol 32(5):1464-1471. (Pubitemid 34546275)
48. Carneiro LA, et al. (2009) Shigella induces mitochondrial dysfunction and cell death in nonmyleoid cells. Cell Host Microbe 5(2):123-136.
49. Tattoli I, et al. (2008) Intracellular bacteriolysis triggers a massive apoptotic cell death in Shigella-infected epithelial cells. Microbes Infect 10(10-11):1114-1123.
50. Clark CS, Maurelli AT (2007) Shigella flexneri inhibits staurosporine-induced apoptosis in epithelial cells. Infect Immun 75(5):2531-2539. (Pubitemid 46744345)
51. Sansonetti PJ (1991) [Molecular and cellular bases of Shigella flexneri virulence]. Bull Acad Natl Med 175(6):803-809. French.
52. Montminy SW, et al. (2006) Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 7(10):1066-1073. (Pubitemid 44420651)
53. Airhart CL, et al. (2008) Induction of innate immunity by lipid A mimetics increases survival from pneumonic plague. Microbiology 154(pt 7):2131-2138.
54. Martinić M, Hoare A, Contreras I, Alvarez SA (2011) Contribution of the lipopolysaccharide to resistance of Shigella flexneri 2a to extreme acidity. PLoS ONE 6(10):e25557.
55. Niu C, et al. (2013) Analysis of Soluble protein complexes in Shigella flexneri reveals the influence of temperature on the amount of lipopolysaccharide. Mol Cell Proteomics 12(5):1250-1258.
56. Chan S, Reinhold VN (1994) Detailed structural characterization of lipid A: Electrospray ionization coupled with tandem mass spectrometry. Anal Biochem 218(1):63-73.
57. Rallabhandi P, et al. (2008) Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling. J Immunol 180(2):1139-1147.
58. Flad HD, Loppnow H, Rietschel ET, Ulmer AJ (1993) Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 187(3-5):303-316. (Pubitemid 23150774)
59. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635-700. (Pubitemid 34800232)
60. Sato S, et al. (2003) Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171(8):4304-4310. (Pubitemid 37238709)
61. Miao EA, et al. (2010) Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA 107(7):3076-3080.
62. Senerovic L, et al. (2012) Spontaneous formation of IpaB ion channels in host cell membranes reveals how Shigella induces pyroptosis in macrophages. Cell Death Dis 3(9):e384.
63. Beatty WL, Sansonetti PJ (1997) Role of lipopolysaccharide in signaling to sub-epithelial polymorphonuclear leukocytes. Infect Immun 65(11):4395-4404. (Pubitemid 27463203)
64. Ingersoll MA, Zychlinsky A (2006) ShiA abrogates the innate T-cell response to Shigella flexneri infection. Infect Immun 74(4):2317-2327.
65. Mandic-Mulec I, Weiss J, Zychlinsky A (1997) Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect Immun 65(1):110-115. (Pubitemid 27008910)
66. Garcia MI, Labigne A, Le Bouguenec C (1994) Nucleotide sequence of the afimbrial-adhesin-encoding afa-3 gene cluster and its translocation via flanking IS1 insertion sequences. J Bacteriol 176(24):7601-7613. (Pubitemid 24382039)
67. Marim FM, Silveira TN, Lima DS, Jr., Zamboni DS (2010) A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PloS One 5(12):e15263.
68. Ermert D, Zychlinsky A, Urban C (2009) Fungal and bacterial killing by neutrophils. Methods Mol Biol 470:293-312.
69. Liu L, Dahlgren C, Elwing H, Lundqvist H (1996) A simple chemiluminescence assay for the determination of reactive oxygen species produced by human neutrophils. J Immunol Methods 192(1-2):173-178. (Pubitemid 26198066)
70. Shi CS, et al. (2012) Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 13(3):255-263.